Bioscience Health Innovations, Inc. (BHIC) stock forecast summary
Our AI scores Bioscience Health Innovations, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Bioscience Health Innovations, Inc. is a small-cap company with a market capitalization of $65M.
It ranks number 53 by market capitalization among the 60 Services-Computer Processing & Data Preparation issuers in our coverage with a current forecast.
For BHIC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 32.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 19.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does.
Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BHIC included.
Price
BHIC price chart and AI forecast
BHIC
Cross-section · 2026-11-06
How BHIC ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Bioscience Health Innovations, Inc. (BHIC) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Computer Processing & Data Preparation peers listed below that report each metric.
Valuation & Market
Metric
BHIC
Industry median
Rank
Market Cap
$65M
$857M
53/60
P/B Ratio
35.16x
2.99x
5/48
EPS
$0.00
–
–
Book Value/Share
$0.16
–
–
Revenue/Share
$0.38
–
–
Profitability & Margins
Metric
BHIC
Industry median
Rank
ROE
-35.9%
8.6%
24/30
ROA
-30.8%
2.2%
26/32
Gross Margin
53.8%
62.0%
26/41
Operating Margin
-13.7%
4.7%
32/46
Net Margin
-14.7%
2.3%
21/32
EBT Margin
-13.7%
3.8%
31/47
Tax Rate
-7.3%
–
–
Financial Health
Metric
BHIC
Industry median
Rank
D/E Ratio
0.16x
1.06x
41/51
Financial Leverage
1.16x
1.94x
36/45
Interest Coverage
-9.2x
1.6x
35/44
Cash Flow
Metric
BHIC
Industry median
Rank
Operating Cash Flow
-$2M
$104M
38/49
OCF Growth YoY
-349.5%
11.3%
31/31
Operational Efficiency
Metric
BHIC
Industry median
Rank
Asset Turnover
2.10x
0.83x
3/33
Receivables Turnover
11.3x
7.5x
10/36
Inventory Turnover
2.6x
8.9x
9/10
Days Sales Outstanding
32 days
49 days
27/36
Days Inventory
140 days
41 days
2/10
Payables Period
2 days
45 days
30/30
Cash Conversion Cycle
171 days
30 days
1/6
Income Statement
Metric
BHIC
Industry median
Rank
Total Revenue
$4M
$838M
37/38
Operating Income
-$610K
$29M
30/48
Net Income
-$660K
$6M
21/34
R&D Expense
$230K
$85M
33/33
SG&A Expense
$2M
$418M
43/43
Cost of Goods Sold
$2M
$238M
41/42
Dividend & Shareholder Information
Metric
BHIC
Industry median
Rank
Shares Outstanding
12M
–
–
Net Income Growth
-169.2%
2.4%
18/20
EPS Growth
-100.0%
14.0%
22/24
Balance Sheet Highlights (USD millions)
Total Current Assets
$2M
93.2% of assets
Cash & Short-term Investments
$710K
33.3% of assets
Accounts Receivable
$400K
18.7% of assets
Inventory
$800K
37.5% of assets
Total Liabilities
$300K
14.1% of assets
Quarterly Financial Reports
BHIC quarterly financials and insider trading
Industry Peers · Services-Computer Processing & Data Preparation
Bioscience Health Innovations, Inc. (BHIC) industry peers
Companies classified under the same SEC industry code as Bioscience Health Innovations, Inc. (Services-Computer Processing & Data Preparation): 60 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Company to acquire 100% of Vitalcore as a wholly owned subsidiary and acquire a 40% ownership interest in an established customer platform serving targeted peptide and wellness buyersBLUFFDALE, UT / ...
BLUFFDALE, UT / ACCESS Newswire / November 6, 2026 / BioScience Health Innovations, Inc. (OTCID:BHIC) ("BHIC" or the "Company"), a diversified health, wellness and life-science company operating ...
About BioScience Health Innovations Inc. BioScience Health Innovations, Inc. engages in developing and distributing preventative health, wellness, and consumer biotech products. Its products include ...
FAQ
Bioscience Health Innovations, Inc. (BHIC) stock forecast FAQ
What is the Bioscience Health Innovations, Inc. (BHIC) stock forecast?
Our AI scores Bioscience Health Innovations, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Bioscience Health Innovations, Inc. stock predictions?
For BHIC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 32.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 19.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Bioscience Health Innovations, Inc. forecasts updated?
Bioscience Health Innovations, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Bioscience Health Innovations, Inc.'s industry peers?
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
AI analystLive data
Intratio Assistant
Ask anything
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.